Prosecution Insights
Prosecution Insights
Technology areas: Biotechnology & Pharmaceuticals • Medical Devices & Mechanical Engineering
24 pending office actions • 12 art units • 23 examiners • 0 of 24 (0%) have an AI response strategy ready • 19 patents granted in the last 365 days
LTS Lohmann Therapie-Systeme AG maintains a robust portfolio with 24 pending office actions in the Biotechnology & Pharmaceuticals technology area. The prosecution workload is highly decentralized, involving 23 distinct examiners. This suggests that the company must navigate a wide array of examiner-specific practices, as almost every pending action is handled by a different official. With the workload spread across 23 examiners, the portfolio lacks a central point of examiner contact.
The portfolio's technical reach extends across 12 distinct art units, indicating a broad application of its pharmaceutical technologies. DONGXIU ZHANG SPIERING is the busiest examiner for the company, currently overseeing 2 pending office actions. This concentration is minimal compared to the total 24 actions, reinforcing the observation that the company's patent strategy is spread across many different points of contact at the office. The presence of 12 distinct art units suggests that the pending matters cover a diverse range of technical sub-specialties within the broader field.
Based on the USPTO statutory response window for each pending office action. 7 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 7 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 10 (42%) |
| §102 only | 1 (4%) |
| Double-patenting + other | 2 (8%) |
| Multi-statute (no §101) | 11 (46%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| ZHANG SPIERING, DONGXIU | 2 | 45.2% | +70.9% |
| SHOMER, ISAAC | 1 | 63.2% | +30.4% |
| ALLEY, GENEVIEVE S | 1 | 60.3% | +48.2% |
| MEYERS, ELIZABETH ANNE | 1 | 23.5% | +92.9% |
| ABU-DAYEH, TAGWA MOHAMMAD | 1 | — | — |
| STRACHAN, KATE ELIZABETH | 1 | 48.2% | +29.2% |
| ROY, DEBJANI | 1 | 75.8% | +15.1% |
| HARM, NICKOLAS R | 1 | 79.5% | +5.8% |
| BAZARGANI, ARYA AHMADI | 1 | 62.5% | +31.3% |
| NGUYEN, LAM S | 1 | 78.8% | +0.2% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18686139 | TRANSDERMAL THERAPEUTIC SYSTEM FOR THE TRANSDERMAL ADMINISTRATION OF GUANFACINE COMPRISING GUANFACINE AND A MONO-CARBOXYLIC ACID | MEYERS, ELIZABETH ANNE | 45d overdue |
| 17421265 | ORAL THIN FILM | KIM, DANIELLE A | 37d overdue |
| 16625401 | SELF-REMINDING PATCH | YU, HONG | 30d overdue |
| 17786223 | TRANSMUCOSAL THERAPEUTIC SYSTEM CONTAINING AGOMELATINE | ZHANG SPIERING, DONGXIU | 19d |
| 17423653 | Support for Microneedle Array | DOUBRAVA, JOHN A | 21d |
| 16765775 | WATER-SOLUBLE POLYMER ADHESIVE LAYERS | HELM, CARALYNNE E | 34d |
| 18272405 | OTF COMPOUND CONNECTED BY SEWING | TIEN, LUCY MINYU | 70d |
| 18692408 | RAPIDLY DISINTEGRATING ORAL THIN-FILMS/FOAMS HAVING A HIGH ACTIVE-INGREDIENT CONTENT BASED ON A MIXTURE OF POLYVINYL ALCOHOLS HAVING VARIOUS MOLECULAR WEIGHTS | ALLEY, GENEVIEVE S | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18686139 | TRANSDERMAL THERAPEUTIC SYSTEM FOR THE TRANSDERMAL ADMINISTRATION OF GUANFACINE COMPRISING GUANFACINE AND A MONO-CARBOXYLIC ACID | MEYERS, ELIZABETH ANNE | 45d overdue |
| 17786223 | TRANSMUCOSAL THERAPEUTIC SYSTEM CONTAINING AGOMELATINE | ZHANG SPIERING, DONGXIU | 19d |
| 18699714 | TRANSDERMAL THERAPEUTIC SYSTEM FOR THE TRANSDERMAL ADMINISTRATION OF TIZANIDINE | SHOMER, ISAAC | — |
| 18692408 | RAPIDLY DISINTEGRATING ORAL THIN-FILMS/FOAMS HAVING A HIGH ACTIVE-INGREDIENT CONTENT BASED ON A MIXTURE OF POLYVINYL ALCOHOLS HAVING VARIOUS MOLECULAR WEIGHTS | ALLEY, GENEVIEVE S | — |
| 18572041 | Method and Device for Impregnating a Film, and Method for Manufacturing a Transdermal Therapeutic System | STRACHAN, KATE ELIZABETH | — |
| 18289948 | Method and Device for Manufacturing Microneedle Elements and a Microneedle Element | ROY, DEBJANI | — |
| 18548690 | ORAL THIN FILM | BAZARGANI, ARYA AHMADI | — |
| 18019505 | ESKETAMINE-SUSPENSION-TTS | ZHANG SPIERING, DONGXIU | — |
| Art Unit | Apps |
|---|---|
| 3783 | 5 |
| 1614 | 3 |
| 1612 | 2 |
| 1617 | 2 |
| 1613 | 2 |
| 1619 | 2 |
| 1616 | 2 |
| 3781 | 1 |
| 1741 | 1 |
| 1745 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18699714 | TRANSDERMAL THERAPEUTIC SYSTEM FOR THE TRANSDERMAL ADMINISTRATION OF TIZANIDINE | SHOMER, ISAAC | 1612 | §103 | Final Rejection | — | Pending | Apr 09, 2024 |
| 18692408 | RAPIDLY DISINTEGRATING ORAL THIN-FILMS/FOAMS HAVING A HIGH ACTIVE-INGREDIENT CONTENT BASED ON A MIXTURE OF POLYVINYL ALCOHOLS HAVING VARIOUS MOLECULAR WEIGHTS | ALLEY, GENEVIEVE S | 1617 | §103§112 | Non-Final OA | — | Pending | Mar 15, 2024 |
| 18686139 | TRANSDERMAL THERAPEUTIC SYSTEM FOR THE TRANSDERMAL ADMINISTRATION OF GUANFACINE COMPRISING GUANFACINE AND A MONO-CARBOXYLIC ACID | MEYERS, ELIZABETH ANNE | 1617 | §103DP | Non-Final OA | 45d overdue | Pending | Feb 23, 2024 |
| 18683548 | Microneedle Device and Method for Detecting At Least One Force Acting on a Microneedle Array | ABU-DAYEH, TAGWA MOHAMMAD | — | §103§112 | Final Rejection | — | Pending | Feb 14, 2024 |
| 18572041 | Method and Device for Impregnating a Film, and Method for Manufacturing a Transdermal Therapeutic System | STRACHAN, KATE ELIZABETH | 3781 | §103 | Final Rejection | — | Pending | Dec 19, 2023 |
| 18289948 | Method and Device for Manufacturing Microneedle Elements and a Microneedle Element | ROY, DEBJANI | 1741 | §103 | Non-Final OA | — | Pending | Nov 08, 2023 |
| 18283560 | Method and Device for Manufacturing an Adherent Film Composite | HARM, NICKOLAS R | 1745 | §103§112 | Final Rejection | — | Pending | Sep 22, 2023 |
| 18548690 | ORAL THIN FILM | BAZARGANI, ARYA AHMADI | 1613 | §103DP | Final Rejection | — | Pending | Sep 01, 2023 |
| 18272678 | Test Equipment for Microneedle Systems, and a Test System and a Method for Testing a Microneedle Application | NGUYEN, LAM S | 2853 | §103 | Non-Final OA | — | Pending | Jul 17, 2023 |
| 18272405 | OTF COMPOUND CONNECTED BY SEWING | TIEN, LUCY MINYU | 1612 | §103§112 | Non-Final OA | 70d | Pending | Jul 14, 2023 |
| 18210144 | MICRONEEDLE SYSTEM FOR THE DELIVERY OF INTERFERON | GREENE, IVAN A | 1619 | §102§103§112Other | Non-Final OA | — | Pending | Jun 15, 2023 |
| 18266740 | Active Ingredient Delivery System | MARRISON, SAMUEL JOSEPH | 3783 | §103 | Non-Final OA | — | Pending | Jun 12, 2023 |
| 18038829 | Sensor Device, Use of a Sensor Device, and Method for Detecting the Properties of a Skin Area | PRETLOW, DEMETRIUS R | 3783 | §102§103 | Non-Final OA | — | Pending | May 25, 2023 |
| 18019505 | ESKETAMINE-SUSPENSION-TTS | ZHANG SPIERING, DONGXIU | 1616 | §103 | Non-Final OA | — | Pending | Feb 03, 2023 |
| 17786235 | TRANSMUCOSAL THERAPEUTIC SYSTEM CONTAINING AGOMELATINE | KASSA, TIGABU | 1619 | §103 | Final Rejection | — | Pending | Jan 31, 2023 |
| 17787874 | SOLUBLE REAR LAYER FOR OTF | PRAGANI, RAJAN | 1614 | §103 | Non-Final OA | — | Pending | Jun 21, 2022 |
| 17786223 | TRANSMUCOSAL THERAPEUTIC SYSTEM CONTAINING AGOMELATINE | ZHANG SPIERING, DONGXIU | 1616 | §103§112Other | Final Rejection | 19d | Pending | Jun 16, 2022 |
| 17638119 | Microarray Applicator and Method for Displacing a Plunger Acting Upon the Microarray | HALL, DEANNA K | 3783 | §102 | Non-Final OA | — | Pending | Feb 24, 2022 |
| 17423509 | Applicator | DIPERT, FORREST BLAKE | 3783 | §103 | Final Rejection | — | Pending | Jul 16, 2021 |
| 17423653 | Support for Microneedle Array | DOUBRAVA, JOHN A | 3783 | §103§112 | Final Rejection | 21d | Pending | Jul 16, 2021 |
| 17421265 | ORAL THIN FILM | KIM, DANIELLE A | 1613 | §103§112 | Final Rejection | 37d overdue | Pending | Jul 07, 2021 |
| 17298551 | TRANSDERMAL THERAPEUTIC SYSTEM WITH DIFFUSION BARRIER | KETCHAM, KAREN A | 1614 | §103 | Final Rejection | — | Pending | May 29, 2021 |
| 16765775 | WATER-SOLUBLE POLYMER ADHESIVE LAYERS | HELM, CARALYNNE E | 1615 | §103§112 | Final Rejection | 34d | Pending | May 20, 2020 |
| 16625401 | SELF-REMINDING PATCH | YU, HONG | 1614 | §103§112 | Non-Final OA | 30d overdue | Pending | Dec 20, 2019 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial